Halbert-
I've never heard that quote from Epstein and I am very doubtful that he ever said that. Do you have a source? It's one thing to say that metastases are never associated with purely a GS6 in the prostate, it's quite another to say that a GS 6 never progresses. Of course it can. And
no one, except those who misunderstand the data, questions that.
For example, look at Klotz's data on Active Surveillance. Although everyone started off with a G6, confirmed by repeated biopsies over 20 years, eventually, about
half of those men reached the GS 4+3 level. Similar data come from Johns Hopkins, which always had annual biopsies as a matter of policy.
The math is convincing. While the odds of missing a higher grade is about
1 in 3 on a single 12-core TRUS-guided biopsy, the odds of missing it on both the original and the repeat biopsy is about
(1/3)^2 or 11%, 4% by the third biopsy, !% by the fourth biopsy, 4 in a thousand by a 5th biopsy, about
1 in a million by the 10th biopsy, etc. When they detect a higher Gleason score after multiple biopsies, it isn't because they keep missing it -- the Gleason score
does progress much of the time. And this is just for TRUS-guided; if it's mpMRI-targeted or template mapping on repeat biopsies, as it often is in the last few years, the odds of missing a higher grade cancer are even less.
I'm correcting you and Gemlin because I think it's very dangerous to tell others this misinformation.
AS advocate -
Cells don't have a Gleason Grade or Pattern - it is a number attached to tissue
architecture, not cells. Parisamour wants to know, if he has a Gleason score of GS 6, if he has a risk of progressing to a higher score. He does. Without question.
Post Edited (Tall Allen) : 9/4/2016 1:20:09 PM (GMT-6)